IE35419L - Pharmaceutical composition containing cyclobenzaprine - Google Patents
Pharmaceutical composition containing cyclobenzaprineInfo
- Publication number
- IE35419L IE35419L IE710845A IE84571A IE35419L IE 35419 L IE35419 L IE 35419L IE 710845 A IE710845 A IE 710845A IE 84571 A IE84571 A IE 84571A IE 35419 L IE35419 L IE 35419L
- Authority
- IE
- Ireland
- Prior art keywords
- pharmaceutical composition
- composition containing
- july
- cyclobenzaprine
- acid addition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
1337068 Skeletal muscle relaxants CHARLES E FROSST & CO 5 July 1971 [7 July 1970] 31334/71 Heading ASB Pharmaceutical dosage units having skeletal muscle relaxant activity comprise (a) 1-25 mg of cyclobenzaprine or an acid addition salt thereof and (b) a carrier. The acid addition salt may be the hydrochloride. The dosage unit may be a tablet for oral administration or an injectable solution in sterile water.
[GB1337068A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA87562 | 1970-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE35419L true IE35419L (en) | 1972-01-07 |
| IE35419B1 IE35419B1 (en) | 1976-02-04 |
Family
ID=4087146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE845/71A IE35419B1 (en) | 1970-07-07 | 1971-07-01 | Muscle-relaxant compositions |
Country Status (15)
| Country | Link |
|---|---|
| BE (1) | BE769517A (en) |
| CA (1) | CA958643A (en) |
| CY (1) | CY885A (en) |
| FR (1) | FR2100873B1 (en) |
| GB (1) | GB1337068A (en) |
| HK (1) | HK4077A (en) |
| IE (1) | IE35419B1 (en) |
| IL (1) | IL37173A (en) |
| KE (1) | KE2690A (en) |
| MT (1) | MTP698B (en) |
| MY (1) | MY7700127A (en) |
| NL (1) | NL7108745A (en) |
| PH (1) | PH12038A (en) |
| ZA (1) | ZA713719B (en) |
| ZM (1) | ZM9571A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991017973A1 (en) * | 1990-05-18 | 1991-11-28 | Merrell Dow Pharmaceuticals Inc. | 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS |
| US5508280A (en) * | 1990-05-18 | 1996-04-16 | Merrell Pharmaceuticals, Inc. | 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists |
| MXPA02001569A (en) | 1999-08-13 | 2002-07-02 | Vela Pharmaceuticals Inc | Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine. |
| CA2380373A1 (en) | 1999-08-13 | 2001-02-22 | Seth Lederman | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
| ITMI20110558A1 (en) * | 2011-04-06 | 2012-10-07 | Campiglio Consulting Srl | PHARMACEUTICAL COMPOSITION CONTAINING CYCLOBENZAPRINE SUITABLE FOR ENDONASAL ADMINISTRATION |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454643A (en) * | 1959-04-27 | 1969-07-08 | Arthur C Cope | 5 - (tertiaryaminoalkylene)-5 hydroxy- and 5-(tertiary aminoalkylidene) - dibenzocycloheptatrienes,and salts thereof |
-
1970
- 1970-07-07 CA CA958643A patent/CA958643A/en not_active Expired
-
1971
- 1971-06-09 ZA ZA713719A patent/ZA713719B/en unknown
- 1971-06-24 NL NL7108745A patent/NL7108745A/xx unknown
- 1971-06-28 IL IL37173A patent/IL37173A/en unknown
- 1971-06-28 MT MT698A patent/MTP698B/en unknown
- 1971-07-01 ZM ZM95/71*UA patent/ZM9571A1/en unknown
- 1971-07-01 IE IE845/71A patent/IE35419B1/en unknown
- 1971-07-01 PH PH12593A patent/PH12038A/en unknown
- 1971-07-05 GB GB3133471A patent/GB1337068A/en not_active Expired
- 1971-07-05 CY CY885A patent/CY885A/en unknown
- 1971-07-05 BE BE769517A patent/BE769517A/en unknown
- 1971-07-07 FR FR7124875A patent/FR2100873B1/fr not_active Expired
-
1977
- 1977-01-06 KE KE2690A patent/KE2690A/en unknown
- 1977-01-20 HK HK40/77A patent/HK4077A/en unknown
- 1977-12-30 MY MY127/77A patent/MY7700127A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE769517A (en) | 1972-01-05 |
| ZM9571A1 (en) | 1973-04-24 |
| PH12038A (en) | 1978-10-16 |
| NL7108745A (en) | 1972-01-11 |
| KE2690A (en) | 1977-01-28 |
| IE35419B1 (en) | 1976-02-04 |
| IL37173A (en) | 1975-02-10 |
| CY885A (en) | 1977-03-18 |
| MTP698B (en) | 1971-11-03 |
| CA958643A (en) | 1974-12-03 |
| FR2100873A1 (en) | 1972-03-24 |
| ZA713719B (en) | 1973-01-31 |
| GB1337068A (en) | 1973-11-14 |
| MY7700127A (en) | 1977-12-31 |
| IL37173A0 (en) | 1971-08-25 |
| FR2100873B1 (en) | 1974-08-02 |
| HK4077A (en) | 1977-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brand et al. | Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods | |
| EP0137542A3 (en) | Pharmaceutical composition for the treatment of states of acute renal insufficiency | |
| GB1310658A (en) | Composition and method for treatment of hepatic disease and mental fatugue | |
| IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
| GB1202148A (en) | Pharmaceutical compositions | |
| GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
| GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
| GB1118606A (en) | Compositions for the treatment of haemorrhoids | |
| GB1375806A (en) | ||
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| GB1327464A (en) | Pharmaceutical composition for inhibiting indoleamine-n- methyl transferase | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| GB1293329A (en) | Pharmaceutical compositions | |
| GB1287433A (en) | Pharmaceutical compositions | |
| AU474505B2 (en) | Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment | |
| GB1300486A (en) | Compositions for the treatment of respiratory ailments in man | |
| GB1310171A (en) | Pharmaceutical products for the treatment of migraine | |
| GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
| GB1422745A (en) | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same | |
| JPS57179118A (en) | Antitumor agent | |
| ES8303915A1 (en) | Pharmaceutical composition of phosphonomicin in tablet form. | |
| GB1339636A (en) | Pharmaceutical compositions for inducing skeletal muscle relaxation | |
| GB1454390A (en) | Nasal decongestants | |
| GB1454872A (en) | Anticonvulsant | |
| IE33519L (en) | Benzylhydrazides |